Reviva Pharmaceuticals Inc. (RVPH) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Reviva Pharmaceuticals I...

    NASDAQ: RVPH · Real-Time Price · USD
    0.46
    -0.05 (-10.63%)
    At close: Aug 27, 2025, 3:59 PM

    Reviva Pharmaceuticals Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a n/a n/a
    Cost of Revenue
    		 n/a n/a n/a n/a
    Gross Profit
    		 n/a n/a n/a n/a
    Operating Income
    		 -30.8M -39.5M -24.31M -10.1M
    Interest Income
    		 361.37K n/a 182.8K n/a
    Pretax Income
    		 -29.9M -39.24M -24.32M -8.52M
    Net Income
    		 -29.92M -39.26M -24.34M -8.52M
    Selling & General & Admin
    		 7.89M 8.08M 5.36M 5.25M
    Research & Development
    		 22.91M 31.42M 18.95M 4.85M
    Other Expenses
    		 n/a n/a n/a n/a
    Operating Expenses
    		 30.8M 39.5M 24.31M 10.1M
    Interest Expense
    		 18.5K n/a 182.8K 2.41K
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 -30.8M 39.5M 24.31M 10.1M
    Income Tax Expense
    		 19.51K -16.95K 20.78K 6K
    Shares Outstanding (Basic)
    		 33.15M 23.8M 19.52M 14.79M
    Shares Outstanding (Diluted)
    		 33.15M 23.8M 19.52M 14.79M
    EPS (Basic)
    		 -0.9 -1.65 -1.45 -0.58
    EPS (Diluted)
    		 -0.9 -1.65 -1.45 -0.58
    EBITDA
    		 -29.88M -39.5M -24.11M -10.1M
    EBIT
    		 -29.88M -39.24M -24.31M n/a
    Depreciation & Amortization
    		 n/a n/a 194.71K 236.56K

    Add to Watchlist